Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Carcinoma, Renal Cell 64Neoplasm Metastasis 25Kidney Neoplasms 21Neoplasms 16Breast Neoplasms 15Carcinoma, Non-Small-Cell Lung 13Urinary Bladder Neoplasms 12Prostatic Neoplasms 10Lung Neoplasms 8Brain Neoplasms 8Melanoma 7Colorectal Neoplasms 7Pancreatic Neoplasms 6Ovarian Neoplasms 6Neuroendocrine Tumors 6Liver Neoplasms 6Glioblastoma 6Gastrointestinal Stromal Tumors 6Carcinoma, Hepatocellular 6Thyroid Neoplasms 5Thymoma 5Small Cell Lung Carcinoma 5Recurrence 5Multiple Myeloma 5Esophageal Neoplasms 5Carcinoma 5Uveal Melanoma 4Stomach Neoplasms 4Sarcoma 4Adenocarcinoma 4

Interventions

Nivolumab 8Specimen Handling 4Ipilimumab 4cabozantinib 3Sunitinib 3Radiosurgery 3pembrolizumab 2pazopanib 2Everolimus 2CTLA-4 Antigen 2Biopsy 2Axitinib 2tivozanib 1sodium-iodide symporter 1sitravatinib 1lenvatinib 1Zoledronic Acid 1Radiotherapy 1Pluvicto 1Nephrectomy 1Metastasectomy 1Magnetic Resonance Spectroscopy 1LY2510924 1Interleukin-2 1Ibandronic Acid 1Diphosphonates 1Denosumab 1Cytoreduction Surgical Procedures 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Clear-cell metastatic renal cell carcinoma × Sunitinib × Clear all
NCT02960906 2021-04-26

BIONIKK

Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie

Phase 2 Completed
200 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma

NCT01391130 2019-07-23

A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Eli Lilly and Company

Phase 2 Terminated
110 enrolled 14 charts
Genitourinary

Clear-cell metastatic renal cell carcinoma, Neoplasm Metastasis, Neoplasms

NCT01499121 2018-03-06

Study of Efficacy and Safety of Sunitinib Given on an Individualized Schedule

Sunnybrook Health Sciences Centre

Phase 2 Completed
117 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡